Facultyof Medicine-Porto University, Portugal.
Pulmonology and Respiratory Intensive Care Unit, S Donato Hospital, Arezzo, Italy.
Pulmonology. 2021 Jul-Aug;27(4):305-312. doi: 10.1016/j.pulmoe.2020.12.005. Epub 2021 Jan 20.
COVID-19 related Acute Respiratory Failure, may be successfully treated with Conventional Oxygen therapy, High Flow Nasal Cannula, Continuous Positive Airway Pressure or Bi-level Positive-Pressure ventilation. Despite the accumulated data in favor of the use of different Non-invasive Respiratory therapies in COVID-19 related Acute Respiratory Failure, it is not fully understood when start, escalate and de-escalate the best respiratory supportive option for the different timing of the disease. Based on the current published experience with Non-invasive Respiratory therapies in COVID-19 related Acute Respiratory Failure, we propose an algorithm in deciding when to start, when to stop and when to wean different NIRT. This strategy may help clinicians in better choosing NIRT during this second COVID-19 wave and beyond.
COVID-19 相关的急性呼吸衰竭,可以通过常规氧疗、高流量鼻导管、持续气道正压通气或双水平正压通气来成功治疗。尽管有大量数据支持在 COVID-19 相关的急性呼吸衰竭中使用不同的无创呼吸治疗,但对于疾病不同阶段最佳呼吸支持选择的起始、升级和降级时机仍不完全清楚。基于目前发表的 COVID-19 相关急性呼吸衰竭中无创呼吸治疗的经验,我们提出了一个算法,用于决定何时开始、何时停止以及何时逐渐减少不同 NIRT 的使用。在第二波 COVID-19 浪潮及以后,该策略可能有助于临床医生更好地选择 NIRT。